Recently, an advisory committee of the U.S. Food and Drug Administration voted in favor of requiring additional trial data in order for a China-trialed medicine to obtain FDA approval. This decision could have major implications for future regulatory approval applications for medicines developed in China. The FDA's

China's Ministry of Industry and Information Technology recently published a revised version of a proposed regulation governing data security in industrial and information sectors. The change, to some extent, broadens the scope of the regulation. The agency previously published the first draft last September.

China and the United Arab Emirates will have mutual recognition of certified operators starting today and China's Customs recently released more information on the implementation.

So far, the China - EU/Lithuania political and trade dispute has been based largely on allegations that are difficult to verify. However, there are now official Chinese government documents that indicate a suspension of some imports from Lithuania, although there is still little in the way of explanation for

Taiwanese officials recently announced that they would loosen an import ban on food from five Japanese prefectures, which was put in place eleven years ago due to concerns over radiation in food produced near the damaged Fukushima Daiichi nuclear power plant. During the same event, officials also updated the progress

Two British government agencies recently announced that they had approved a nuclear reactor designed by a Chinese firm. However, the company's involvement in this and other nuclear projects in the UK remains unclear, as other British government officials and members of the UK parliament have both been pushing

China's food certification agency recently published more details on the implementation of mutual recognition of organic products with New Zealand. On the same day, the New Zealand government also issued a document outlining details for its domestic exporters.